Key result
Myocyte-specific transgenic expression of Ighmbp2 increased the lifespan of nmd mice up to 8-fold by preventing primary dilated cardiomyopathy and completely correcting cardiac function.
Effect estimate: up to 8-fold increase in lifespan
Tissue-specific expression of IGHMBP2 in cardiomyocytes prevents dilated cardiomyopathy and extends lifespan in a mouse model of neuromuscular degeneration, highlighting its essential role in cardiomyocyte maintenance.
No takes yet. Share an insight, caveat, or question.
No immediate clinical implications; leaves open whether cardiomyocyte-targeted IGHMBP2 therapy could translate to human neuromuscular disease.
Maddatu et al. (2005) studied Dilated cardiomyopathy (DCM) and motor neuron disease. Transgenic expression of full-length Ighmbp2 cDNA in myocytes was evaluated on Lifespan and cardiac function (up to 8-fold increase in lifespan). Myocyte-specific transgenic expression of Ighmbp2 increased the lifespan of nmd mice up to 8-fold by preventing primary dilated cardiomyopathy and completely correcting cardiac function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: